Previous Article | Next Article 
Molecular and Cellular Biology, August 2001, p. 5071-5081, Vol. 21, No. 15
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.15.5071-5081.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Early Expressed Clb Proteins Allow Accumulation of
Mitotic Cyclin by Inactivating Proteolytic Machinery during S
Phase
Foong May
Yeong,
Hong Hwa
Lim,
Ya
Wang, and
Uttam
Surana*
Institute of Molecular and Cell Biology,
Singapore 117609, Singapore
Received 2 March 2001/Returned for modification 17 April
2001/Accepted 8 May 2001
 |
ABSTRACT |
Periodic accumulation and destruction of mitotic cyclins are
important for the initiation and termination of M phase. It is known
that both APCCdc20 and APCHct1 collaborate to
destroy mitotic cyclins during M phase. Here we show that this
relationship between anaphase-promoting complex (APC) and Clb proteins
is reversed in S phase such that the early Clb kinases (Clb3, Clb4, and
Clb5 kinases) inactivate APCHct1 to allow Clb2
accumulation. This alternating antagonism between APC and Clb proteins
during S and M phases constitutes an oscillatory system that generates
undulations in the levels of mitotic cyclins.
 |
INTRODUCTION |
Oscillation in the abundance of
mitotic cyclins is a major driving force for the progression through
mitosis. While mitotic entry requires the accumulation of these
cyclins, the exit is dependent on their destruction.
Generally, a combination of transcriptional and posttranslational
controls determines the appropriate levels of cyclins at particular
stages of the cell cycle. In the budding yeast Saccharomyces cerevisiae, the transcription of mitotic cyclins Clb1 and Clb2 is
cell cycle regulated such that their mRNA levels rise in late S phase,
peak in G2/M, and finally decline at the end of M
phase (4, 5, 16). Crucial to the posttranslational
regulation of cyclin abundance is the ubiquitin-dependent proteolytic
machinery. A ubiquitin ligase called the anaphase-promoting complex
(APC) is essential for the mitotic cyclin degradation necessary for the
exit from mitosis (26). In yeast, the APC is a multimeric complex consisting of at least 12 subunits (24) which
requires the activator protein Cdc20 or its homolog Hct1 (also known
as Cdh1) (9, 12, 18). While the APC activated by
Cdc20 (APCCdc20) promotes chromosome
segregation by causing destruction of the anaphase inhibitor Pds1,
APCHct1 plays a role in the final exit from
mitosis by mediating proteolytic degradation of the mitotic cyclin Clb2
(12, 18). Hct1 phosphorylation by mitotic kinases prevents
it from activating APC (6, 23). The removal of this
inhibitory phosphorylation by Cdc14 phosphatase (19) is a
critical step which allows Hct1 to bind to and activate APC (7,
23). The activity of Cdc14 itself is under the control of the
mitotic exit network pathway that includes regulatory proteins such as
Tem1, Cdc15, and Net1 (25). Interestingly, Cdc20 function is also essential for the exit from mitosis (9, 21). It
has been suggested elsewhere that Cdc20 promotes exit from mitosis solely by catalyzing the destruction of S-phase cyclin Clb5
(14). However, according to a less deterministic scheme,
APCCdc20 facilitates activation of
APCHct1 by causing progressive lowering of the
inhibitory Clb-Cdc28 kinase activities by partial destruction of Clb
proteins (3, 22). A reduction in the collective Clb kinase
activities would allow a net increase in the dephosphorylation of Hct1
by Cdc14 phosphatase. A fully active APCHct1 can
then target the remaining Clb2 for degradation during telophase, thus
easing the cells out of mitosis. It is widely believed that, once
activated in mitosis, this proteolytic machinery is turned off by the
Cln kinases at the onset of the next cycle (2).
Although Clb5 along with other Clbs may prevent untimely exit from
mitosis, we show here that the early Clbs collectively also have an
essential role during S phase. We demonstrate that it is the early Clb
kinase complexes (Clb3, Clb4, and Clb5) that inactivate
APCHct1 in S phase. Their ability to suppress the
APCHct1 activity early in the cycle is necessary
for the effective expression and accumulation of late mitotic cyclins
(such as Clb2) critical for the onset of mitosis. This regulation is a
reversal of the scenario in M phase, where APC ensures the inactivation
of Clb proteins. We suggest that such a periodic reversal of antagonism between APC and Clb proteins during S and M phases is critical in
generating basic oscillations in the levels of major mitotic cyclins.
 |
MATERIALS AND METHODS |
Yeast media and reagents.
All strains used in this study are
congenic to the wild-type strain W303. Cells were grown in yeast
extract-peptone (YEP) or selective medium supplemented with 2% glucose
(+Glu) or 2% raffinose plus galactose (+Raff +Gal).
Kanamycin-resistant colonies were selected on plates containing G418
(200 mg/liter).
Strains and plasmids.
The strains (Table
1) were constructed by a combination of
standard molecular genetic techniques such as gene transplacement, gene
disruption, and tetrad dissection. Southern blot analysis was performed
to confirm gene disruptions and transplacements.
CDC14-GFP was constructed by subcloning a 0.9-kb
XhoI-
KpnI green fluorescent protein (GFP)
fragment (from Pam Silver's lab)
into
XhoI-
KpnI
sites introduced at the 3' end of a 3.1-kb
CDC14 fragment.
GAL-HA3-HCT1 was made by ligating a
SpeI-
SalI (1.8-kb)
fragment containing
HA3-HCT1 from pWS 216 (W. Seufert)
to
XbaI-
SalI-digested
Ycplac22 carrying a
GAL1-10 promoter. To construct
MET3-CLB2-HA3,
a
MET3 promoter
(0.6 kb,
EcoRI-
KpnI) was subcloned into
EcoRI-
KpnI-digested
Ycplac111. This was then
digested with
EcoRI and ligated to a
2.1-kb
EcoRI
CLB2-HA3 fragment.
For
MET3 HA3-HCT1, Ycplac111
carrying the
MET3 promoter was cut with
EcoRI,
filled in, and ligated to a blunted
HA3-HCT1 (1.8-kb
SpeI-
SalI) fragment from pWS 216 (W. Seufert).
The construct was
then transferred to YEplac181 using
SalI-
XbaI sites. An
HCT1::KAN disruption cassette was made by
replacing the
NheI-
BlpI fragment
of
HCT1 with the
KAN MX2 resistance marker. The
3.3-kb
EcoRI-
XbaI
fragment was used for gene
disruption.
An
MET3-CLN2-HA3 cassette was made by
ligating a
SalI-
SpeI fragment containing the
MET3 promoter and the 5' end of
CLN2 to
a
SpeI-
EcoRI fragment containing the 3' end of
CLN2-HA3 with the
3' untranslated region
and part of a
LEU2 marker. This cassette
was subcloned onto
a 2µm plasmid carrying a
KAN MX2 marker. The
plasmid
backbone was constructed from pFL38 where the
BglII-
BglII
fragment (
URA3 sequences)
had been replaced by a
SalI-
SpeI fragment
(
KAN MX2 marker). A
ClaI fragment containing
2µm sequences was
inserted at the
NarI site of the
multiple cloning
site.
Cell synchronization, cell extracts, kinase assays, and Western
blot analysis.
To obtain synchronous cultures, exponential-phase
cells were grown in medium at 24°C containing either
factor (5 µg/ml for BAR1 cells and 0.8 µg/ml for bar1
cells) or 30 mg of hydroxyurea (HU) or nocodazole (15 µg/ml) per ml
for 3 to 4 h. Lysates for whole-cell extracts were prepared, and
kinase assays were performed according to the method of Surana et al.
(17). Western blot analyses were performed as described in
the work of Yeong et al. (22).
Northern blot hybridization, flow cytometry, and
immunofluorescence staining.
The RNA extraction procedure,
Northern blot analysis, flow cytometry analysis, and immunofluorescence
staining were carried out as described by Lim et al. (8).
Immunofluorescence signals were detected using the Leica DM microscope,
and images were acquired using an attached Hamamatsu charge-coupled
device camera driven by the MetaMorph (Universal Imaging Corporation) software.
 |
RESULTS |
Absence of Clb5 limits Clb2 accumulation in late S phase.
We
have previously reported that Cdc20 function is essential for the final
exit from mitosis (9). We had also shown previously that
Cdc20's role in mitotic exit is to catalyze Clb protein destruction to
varying degrees during the cell's approach to telophase, thus lowering
the collective Clb kinase activities to facilitate Hct1 activation by
Cdc14 phosphatase (22). Interestingly, a mutation in the
S-phase cyclin CLB5 gene alone was found to be sufficient to
allow cells to exit mitosis in the absence of the CDC20 gene (14), leading to the proposal that Cdc20 allows mitotic
exit solely by causing destruction of Clb5 at metaphase. However, it seems puzzling that an S-phase cyclin, which is normally destroyed by
the time that cells are in metaphase (11), could be
responsible for inhibiting Hct1 just prior to exit from mitosis. To
address this, we asked whether the absence of the CLB5 gene
causes an overall change in the levels of mitotic cyclin. The wild-type and clb5
cells carrying CDC14-GFP (at its
native locus) were synchronized in G1 by
-factor treatment and then released into
-factor-free medium at
24°C. In the wild-type strain, Clb2 protein rose approximately
15-fold relative to its level in
-factor arrest before beginning its
decline at 120 min (Fig. 1, left panels). In clb5
cells, on the other hand, Clb2 levels increased
only three- to fourfold compared to the level in
G1 (Fig. 1, right panels). This is clearly not
due to a difference in the extent of synchrony, because the two
cultures showed comparable degrees of synchrony (see graphs). These
results suggest that a lack of Clb5 function compromises significantly
the cells' ability to build up Clb2 protein (and most likely Clb1),
though the reduced amount is still sufficient to allow onset of
mitosis. They also imply that the reason why deletion of the
CLB5 gene allows exit from mitosis in the Cdc20-deficient
cells is that, in the absence of Clb5, the collective Clb kinase
activities do not build up to the wild-type level; consequently, Cdc20
function is no longer required to reduce the overall Clb kinase
activities any further for the effective activation of Hct1 by Cdc14
phosphatase.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 1.
Reduced levels of Clb2 protein in the
clb5 mutant. Wild-type cells (US2340) and
clb5 cells carrying CDC14-GFP
integrated at the CDC14 locus (US2337) were arrested in
G1 with factor and then released into YEP+Glu medium at
a permissive temperature. Samples were analyzed for the budding index,
nuclear division, and Clb2 and Cdc28 protein levels.
|
|
Early transcribed CLB3, CLB4, and
CLB5 genes are collectively essential for accumulation
of late mitotic cyclin Clb2.
It has been reported previously that,
while both clb3
clb4
and clb5
strains are viable (5, 13), clb3
clb4
clb5
triple mutant cells fail to
survive (13); they arrest prior to mitosis with 2N DNA
content and a single nucleus but completely lack a mitotic spindle. The
explanation put forward for the inviability is that, in the absence of
Clb3 and Clb4, Clb5 becomes essential for the biogenesis of mitotic
spindle (13); thus, the clb3
clb4
clb5
mutant fails to form a spindle
and eventually loses viability. Prompted by our finding that
clb5
cells are compromised in their ability to accumulate
Clb2, we determined the extent to which the collective deficiency in
CLB3, CLB4, and CLB5 might affect the
level of Clb2 protein. Wild-type and clb3
clb4
clb5
strains kept alive by
GAL-CLB5 integrated at the TRP1 locus were synchronized in G1 by
-factor treatment and
then allowed to resume cell cycle progression in glucose medium at
24°C. As expected, the abundance of both CLB2 transcript
and the protein showed oscillatory behavior in the wild-type strain
(Fig. 2A,
left panel). CLN1 transcript appears slightly earlier and
also shows characteristic fluctuation as cells continue to course
through the cycle. The clb3
clb4
clb5
cells were released normally from their
G1 arrest but soon accumulated at
G2/M with an elongated bud, 2N DNA content (data not shown), and an undivided nucleus lacking a mitotic spindle (Fig.
2B, right panel). Surprisingly, the levels of both CLB2 transcript and the Clb2 protein remained low in these cells throughout the experiment (Fig. 2A). The CLN1 transcript appeared
within 20 min of release from G1 arrest but,
unlike that in wild-type cells, persisted throughout the time course.
This is consistent with an earlier report that, in the absence of Clb
kinases, cells are unable to turn off CLN1 transcription
effectively (1). These results suggest that cells lacking
CLB3, CLB4, and CLB5 can neither
effectively transcribe the CLB2 gene nor accumulate Clb2
protein. Most likely, this is also true of the CLB1 gene since CLB1 and CLB2 are similarly regulated
(4, 5).


View larger version (82K):
[in this window]
[in a new window]
|
FIG. 2.
(A) clb3 clb4
clb5 cells arrest in G2/M with low levels
of CLB2 transcript and Clb2 protein. Wild-type cells
(US356) and clb3 clb4
clb5 GAL-CLB5::TRP1 cells
(US2417) were synchronized in G1 by -factor treatment
and then released in YEP+Glu medium at 24°C. Samples were collected
at 20-min intervals and analyzed for the state of nuclear division,
CLB2 and CLN1 RNA transcripts, and the
levels of Clb2 and Cdc28 proteins. (B) clb3
clb4 clb5 cells arrest in
G2/M without a mitotic spindle. Left panels, wild-type
cells with long mitotic spindles in the 100-min sample from the
experiment described for panel A; right panels, clb3
clb4 clb5 cells in 100- and 240-min
samples, clearly lacking mitotic spindles. DAPI,
4',6'-diamidino-2-phenylindole. (C) clb3
clb4 clb5 cells survive in the
presence of MET3-CLB2-HA3. The
clb3 clb4 clb5
GAL-CLB5::TRP1 control cells (US2417) were
plated on either YEP+Gal (top left sector) or YEP+Glu (top right
sector) plates. clb3 clb4
clb5 GAL-CLB5::TRP1 cells
carrying MET3-CLB2-HA3 on a
CEN plasmid (US2435) were plated on a Met+Glu plate
(bottom right sector). The plates were incubated at 24°C and
photographed after 48 h. (D) Clb2 is unstable in S phase in
clb3 clb4 clb5
cells. Wild-type cells (US2404) and clb3
clb4 clb5 cells carrying
MET3-CLB2-HA3 on a CEN
plasmid (US2435) were arrested in early S phase by growth in
YEP+Glu+Met medium containing HU (30 mg/ml). After 3 h, the
cultures were filtered and cells were resuspended in Met+Glu+HU for
40 min. Methionine was added to the cultures to repress transcription,
and samples, collected for a further 90 min, were analyzed for
Clb2-HA3 and Cdc28 protein levels.
|
|
Taken together, these observations imply that the inviability of
clb3
clb4
clb5
cells may be
due to a severe deficiency
of Clb1 and Clb2 proteins. Although the
native promoter-driven
CLB2 gene on a 2µm plasmid cannot
rescue
clb3
clb4
clb5
cells
(
13), strikingly,
CLB2 expressed from the
MET3 promoter on a
CEN vector allows them to form
healthy colonies (Fig.
2C). This
observation is consistent with the
notion that the
clb3
clb4
clb5
cells die due to a lack of Clb2 protein (and perhaps
Clb1)
and suggests that, in the absence of Clb3, Clb4, and Clb5, the
native promoter of
CLB2 is not fully
active.
Clb2 is unstable in clb3
clb4
clb5
cells.
It is known that the native
CLB2 promoter is under positive feedback control; i.e.,
unlike the MET3 promoter, efficient transcription from the
native promoter requires Clb2-Cdc28 activity (1). One
reason why the clb3
clb4
clb5
mutant is unable to effectively transcribe CLB2 and
accumulate Clb2 may be because Clb2 is unstable in these cells. To test
this notion, wild-type and clb3
clb4
clb5
cells carrying
MET3-CLB2-HA3 on a CEN vector
were synchronized in early S phase by HU treatment in the presence of
methionine (+Met) and then transferred to
Met medium to induce
Clb2-HA3 protein. The induction was terminated
after 40 min by the addition of methionine, and the stability of the
protein was monitored by Western blot analysis. The cell cycle arrest
was maintained throughout the experiment by the presence of HU in the
medium at all times. The Clb2-HA3 protein,
ectopically expressed during the short pulse period, remained stable in
wild-type cells (Fig. 2D, left panel), indicated by its unchanged
abundance at various time points. In clb3
clb4
clb5
cells, however,
Clb2-HA3 begins to dissipate at 40 min and is
barely detectable by 60 min, suggesting that the absence of Clb3, Clb4,
and Clb5 makes Clb2 highly unstable (Fig. 2D, right panel).
clb3
clb4
clb5
cells are unable to phosphorylate Hct1
efficiently.
Since APCHct1 targets Clb2 for
proteolytic degradation in telophase and in G1 of
the subsequent division cycle, we suspected that the instability of
Clb2 in clb3
clb4
clb5
cells
might be due to hyperactive Hct1 during S and G2
phase. This may result either from premature release of Cdc14 from the
nucleolus or from incomplete inactivation of
APCHct1 (due to underphosphorylation of Hct1)
during S phase. Therefore, we first examined the localization of Cdc14
in clb5
cells described for the experiment whose results
are shown in Fig. 1. In both wild-type and clb5
cells,
Cdc14-GFP remained sequestered in the nucleolus until the onset of
sister chromatid separation, after which it was dispersed for a short
period (Fig.
3A). The
dispersion of Cdc14 from nucleolus during the metaphase-anaphase
transition has been well documented elsewhere (15, 20).
Hence, the deficiency of CLB5 does not lead to premature
dispersion of Cdc14.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 3.
(A) Cdc14-GFP is not prematurely dispersed in
clb5 cells. Wild-type (left panels) and
clb5 (right panels) samples at various times are
shown. The graphs depict the extents of nuclear division and Cdc14-GFP
dispersion. DAPI, 4',6'-diamidino-2-phenylindole. (B) Insufficient
phosphorylation of Hct1 in a clb5 strain. Wild-type
(US2352) and clb5 (US2354) cells carrying
GAL-HA3-HCT1 were arrested in
G1 by -factor treatment in YEP+Raff+Gal at 24°C. The
cultures were filtered, washed, and resuspended in YEP+Glu at 24°C.
Samples were analyzed for DNA content, nuclear division index, Cdc28
protein levels, and Hct1 phosphorylation. (C) Inefficient
phosphorylation of Hct1 in clb3
clb4 clb5 cells.
clb3 clb4 clb5
cells carrying MET3-HA3-HCT1 on
a 2µm plasmid (US2438) were synchronized in G1 by
-factor treatment for 3 h (the first 1.5 h in YEP+Raff+Met
and the second 1.5 h in Met+Raff medium). The culture was
divided into two halves; one-half of the cells were resuspended in
YEP+Raff+Met, and the other half were resuspended in YEP+Gal+Met.
Samples were analyzed for DNA content, Hct1 phosphorylation, and Clb2
and Cdc28 protein levels.
|
|
The effect of Clb5 deficiency on the phosphorylation of Hct1 was
determined in cells expressing Hct1 under the control of
the
GAL1 promoter since the wild-type level of Hct1 is not
easily
detectable in our Western blot analysis. Wild-type and
clb5
cells
carrying
GAL-HA3-HCT1 on a
CEN
plasmid were subjected to the experimental
conditions described for
Fig.
1, and the extent of Hct1 phosphorylation
was monitored at various
times. During

-factor arrest, Hct1 is
predominantly in
nonphosphorylated form in both wild-type and
clb5
cells
(Fig.
3B). In wild-type cells, Hct1 appears as a single
band at a
higher position on the gel within 90 min after the release,
indicating
modification. However,
clb5
cells fail to fully convert
Hct1 to a single, low-mobility band (Fig.
3B); instead, multiple
bands
are seen throughout the course of the experiment. Since
Hct1 contains
at least nine potential phosphorylation sites (
23),
these
multiple bands most likely represent different phosphorylated
forms.
These results suggest that
clb5
cells are compromised
in
their ability to modify Hct1 completely. It is possible that
a
significant proportion of Hct1, which remains underphosphorylated
in
clb5
cells, is sufficient for the continuous destruction
of
Clb2 throughout the cell cycle, thereby preventing Clb2 from rising
to the wild-type level (Fig.
1).
To determine if Hct1 is also underphosphorylated in the absence of
CLB3,
CLB4, and
CLB5 genes,
clb3
clb4
clb5
cells carrying
one copy of
GAL-CLB5 (integrated at the
TRP1
locus) and
MET3-HA3-HCT1 on a 2µm
vector were synchronized in G
1 by

-factor
treatment
for 3 h at 24°C. The last 1.5 h of

-factor
treatment was carried
out in

Met+Raff medium to induce the synthesis
of HA
3-Hct1. Cells
were then released in either
YEP+Raff+Met (no Clb5) or YEP+Raff+Gal+Met
medium (Clb5 induction).
Hct1 first appears as a nonphosphorylated,
single band (Fig.
3C,

-factor lane). In the culture where Clb5
was induced (Fig.
3C, right
panel), Hct1 phosphorylated to different
extents can be seen within 60 min, as indicated by the appearance
of low-mobility bands (Fig.
3C,
right panel). By 90 min, most
of Hct1 shifts upward. This is
accompanied by the appearance of
Clb2 protein (90- and 120-min lanes).
In cells devoid of Clb5,
a discernible amount of unphosphorylated Hct1
is still present
even at 120 min (Fig.
3C, left panel). In addition, no
Clb2 protein
is detected in these cells. These findings suggest that
cells
deficient in Clb3, Clb4, and Clb5 are inefficient in
phosphorylating
Hct1 and are therefore unable to inactivate it
completely. This
results in the inability of these cells to accumulate
Clb2. It
is noteworthy that, in the absence of Clb3, Clb4, and Clb5,
Hct1
is still phosphorylated to some extent though not sufficiently
to
allow growth. We suspect that this could be due to fully functional
Clb6-Cdc28 kinase and Cln kinases present in these cells. However,
the
severe consequences elicited by the absence of Clb3, Clb4,
and Clb5
suggest that phosphorylation by Clb6 and Cln kinases
is clearly not
sufficient to inactivate Hct1. These results imply
that early Clb
kinases (Clb3-Cdc28, Clb4-Cdc28, and Clb5-Cdc28)
play a critical role,
by inhibiting Hct1 through phosphorylation,
in the accumulation of Clb2
to an appropriate
level.
Deletion of HCT1 relieves G2/M arrest in
clb3
clb4
clb5
cells.
The data presented in the preceding sections argued that
clb3
clb4
clb5
cells fail to
enter mitosis because of their inability to inactivate Hct1. An
important prediction of this claim is that a deletion of the
HCT1 gene should allow clb3
clb4
clb5
cells to undergo nuclear division. We therefore
constructed an hct1
clb3
clb4
clb5
quadruple-deletion mutant carrying one copy of
GAL-CLB5 integrated at the TRP1 locus. While the
clb3
clb4
clb5
triple mutant
completely fails to grow on glucose plates, the hct1
clb3
clb4
clb5
mutant forms
viable colonies (Fig. 4B). Microscopic
examination revealed that not all quadruple mutant cells survived;
however, they did appear to have undergone a few divisions before
losing viability. We deemed it necessary to establish more clearly the
ability of the quadruple mutant to undergo nuclear division. Since
cells deficient in Hct1 are somewhat resistant to pheromone treatment,
clb3
clb4
clb5
and
hct1
clb3
clb4
clb5
cells carrying GAL-CLB5 were synchronized
in a pre-nuclear-division state by treatment with the
microtubule-disrupting agent nocodazole in galactose medium. Cells were
then released into glucose medium to allow them to progress through the
cycle in the absence of Clb5. As expected, clb3
clb4
clb5
cells reassembled mitotic spindles, underwent nuclear division within 40 min, and then exited mitosis as indicated by the disappearance of Clb2 protein (Fig. 4A,
left panel). Within the next 60 min, they entered the next cycle (fresh
buds) but eventually arrested with an elongated bud and an undivided
nucleus devoid of mitotic spindle (Fig. 4C, left panels). As described
in a previous section (Fig. 3), the level of Clb2 protein remained
barely detectable after 100 min in these cells (Fig. 4A, left panel).
The clb3
clb4
clb5
cells
lacking HCT1 also reassembled the mitotic spindle, divided
the nucleus, and exited mitosis. They entered the next cycle,
reassembled the mitotic spindle, and continued through the cycle as
indicated by the presence of divided nuclei with an elongated spindle
(Fig. 4C). Moreover, the Clb2 protein also accumulates in these cells (Fig. 4A, left panel). However, the reaccumulation of Clb2 is not
dramatic, perhaps due to a low degree of synchrony in cells released
from nocodazole arrest. Nevertheless, these results suggest that
HCT1 deletion indeed allows mitotic entry in
clb3
clb4
clb5
cells. Thus,
the collective essential function of these early transcribed
CLB genes is to inactivate Hct1, making way for the
accumulation of Clb2 (and Clb1) necessary for the onset of mitosis.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 4.
(A) Deletion of HCT1 relieves
G2/M arrest in clb3
clb4 clb5 cells.
clb3 clb4 clb5
GAL-CLB5::TRP1 (US2417) and
clb3 clb4 clb5
hct1 GAL-CLB5::TRP1 (US2440)
cells were treated with nocodazole (15 µg/ml) for 3.5 h in
YEP+Gal at 24°C. The cells were washed and resuspended in YEP+Glu.
Clb2 and Cdc28 protein levels were monitored in samples collected at
20-min intervals. (B) Deletion of HCT1 allows
clb3 clb4 clb5
cells to grow on YEP-Glu medium. (C) Deletion of HCT1
relieves G2/M arrest in clb3
clb4 clb5 cells. The left panels
show cells from the experiment described for panel A. clb3 clb4 clb5
cells form a mitotic spindle within 40 min after the release from
nocodazole arrest but eventually are blocked in G2/M of the
subsequent cycle without mitotic spindles (260-min sample). The right
panels show that clb3 clb4
clb5 hct1 cells have reassembled
spindles (80-min sample) after the release and continue to progress
through the next cycle as indicated by the presence of mitotic spindles
of various sizes (180-min sample). Noc, nocodazole; DAPI,
4',6'-diamidino-2-phenylindole.
|
|
Clb-Cdc28 complexes are critical for switching off proteolysis in
early S phase.
It is generally believed that the proteolytic
machinery responsible for mitotic cyclin destruction is turned off
early in the subsequent cycle by Cln-Cdc28 kinase (1).
However, in direct contrast with this, our data suggest that
APCHct1 activated during late mitosis is
inactivated by Clb (Clb3, Clb4, and Clb5) kinases in the subsequent
cycle. Consequently, clb3
clb4
clb5
cells are unable to inactivate
APCHct1 and die due to a severe deficiency of
Clb2 (and most likely of Clb1). If so, then the cyclin kinase that
inactivates the proteolytic machinery would be expected to restore the
accumulation of Clb2 protein in clb3
clb4
clb5
cells. We therefore compared the abilities of
GAL-CLB5 (single copy) and MET3-CLN2 (on a 2µm
vector) to reinstate the expression of CLB2. clb3
clb4
clb5
GAL-CLB5 cells were
synchronized by
-factor treatment in YEP+Raff at 24°C and allowed
to resume the cell cycle in YEP+Raff, while clb3
clb4
clb5
GAL-CLB5 cells
carrying MET3-HA3-CLN2 on a 2µm
plasmid were treated with
factor in YEP+Glu medium and were
released in YEP+Glu+Met medium. After 2 h, galactose was added to
cells without MET3-HA3-CLN2 to
induce synthesis of Clb5, whereas those with
MET3-HA3-CLN2 were shifted to
Met+Glu medium to induce Cln2. While both Clb2 protein and
CLB2 transcript began to accumulate within 40 min of Clb5
induction, expression of Cln2 did not alter Clb2 expression, which
remained at a basal level throughout the experiment (Fig.
5A). These results strengthen the notion
that it is the early Clb kinases which make Clb2 accumulation possible. This is further supported by the fact that, while both
GAL-CLB5 and MET3-CLB2 can efficiently rescue
clb3
clb4
clb5
cells, a
chronic expression of Cln2 from the MET3-CLN2 construct on a 2µm vector is unable to do so (Fig. 5B). However, it must be noted that our results do not completely rule out the possibility that Cln
kinases may contribute toward APCHct1
inactivation to some extent, perhaps early in the cell cycle prior to S
phase.

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 5.
(A) Cln2 expression does not result in Clb2
accumulation. clb3 clb4
clb5 GAL-CLB5 (US2417) cells were
arrested in G1 with factor in YEP+Raff. The culture was
filtered, and cells were resuspended in YEP+Raff for 2 h.
Galactose (2%) was then added to induce the synthesis of Clb5 for
2 h. In parallel, clb3 clb4
clb5 GAL-CLB5
MET3-HA3-CLN2 (US2439) cells,
synchronized in G1 by -factor treatment in YEP+Glu+Met,
were filtered and resuspended in YEP+Glu+Met for 2 h. Cells were
then transferred to Met+Glu medium to induce the synthesis of
HA3-Cln2 for 2 h. Samples were analyzed for Clb2 and
Cdc28 protein levels and CLB5, CLB2, and
CLN2 RNA levels. (B) Overexpression of Cln2 is unable to
restore viability in clb3 clb4
clb5 cells. clb3
clb4 clb5 GAL-CLB5
cells were plated on either glucose (upper right) or galactose (upper
left) plates, whereas clb3 clb4
clb5 GAL-CLB5
MET3-HA3-CLN2 cells were plated on
Met+Glu medium. Plates were photographed after 3 days at 24°C.
|
|
Contribution of transcriptional regulation to oscillations in Clb2
abundance.
The results described above suggest that, while APCs
act to inactivate Clb kinase complexes in M phase, some of the Clb
kinases cooperate to inactivate APCHct1 during S
phase to allow accumulation of mitotic cyclins. This also implies that
such an alternating antagonism between APC and Clb kinases in S and M
phases should be able to generate oscillations in Clb2 levels. If so,
then to what extent does the fluctuating transcription of
CLB2 contribute to these oscillations? We addressed this in
a strain where CLB2 is transcribed, not periodically from its native promoter, but continuously from the ADH promoter.
The wild-type strain and a strain in which the endogenous
CLB2 gene had been replaced by ADH-CLB2 were
synchronized in G1 by pheromone treatment at
24°C. Cells were allowed to resume cell cycle progression in
pheromone-free medium. As expected, Clb2 protein showed oscillatory behavior for two synchronous cycles in wild-type cells (Fig.
6; lower panels, solid diamonds). Cells
carrying ADH-CLB2 also exhibited the oscillatory pattern in
the abundance of Clb2 (Fig. 6, lower panels, open circles). However,
compared to the wild type, the amplitude of the oscillation in these
cells was lower in the first cycle; the reduction in the amplitude was
even more pronounced in the second division cycle. These observations
imply that while the mutually repressive behavior of APC and Clb
proteins is sufficient for producing basic oscillations in Clb2
protein, transcriptional regulation modulates the amplitude of these
oscillations.

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 6.
The oscillatory pattern in Clb2 protein levels is
maintained even when CLB2 transcription is constitutive.
Wild-type (US356) ( ) and clb2
ADH-CLB2 (US164) ( ) cells, synchronized in
G1 by -factor treatment in YEP+Glu at 24°C, were
released into YEP+Glu medium. The state of mitotic spindles and the
levels of Clb2 and Cdc28 proteins and CLB2 transcript
are shown.
|
|
 |
DISCUSSION |
A quick rise and a rapid fall in mitotic cyclin levels within a
division cycle are important for the orderly progression through M
phase. The cellular logistics which give rise to this oscillatory behavior are also of great interest because they promise a glimpse into
the regulatory dynamics that generate such a pattern. The cyclic
fashion in which the major mitotic cyclins appear and disappear has
been attributed to the onset of cyclin transcription in late S phase
and destruction in late telophase, respectively. As a coarse
approximation, this indeed appears to be true. However, such a
simplistic view overlooks entirely the dynamic realities of cellular
events that generate such a periodic pattern.
It has been well documented elsewhere that the high mitotic kinase
(such as Clb2 kinase) activity keeps Hct1 in an inactive state
(6) and thus prevents cells from exiting mitosis. In vitro
assays have shown that Hct1 can also be phosphorylated by Clb5 kinase
(23). Consistent with these findings, it has been reported
elsewhere that Clb5 destruction at the onset of anaphase is required to
pave the way for Hct1 activation and hence mitotic exit
(14). However, these studies do not in any way address the
role that Clb5 (and other early Clb proteins) may play in inactivating
proteolytic machinery during early S phase. Although APCHct1 activated in telophase is responsible for
keeping mitotic cyclin levels to a minimum during
G1, it becomes a detriment to cells as they
attempt to reaccumulate mitotic cyclins (Clb1 and Clb2) at the onset of
mitosis. In this report, we show that the inactivation of
APCHct1 in early S phase is accomplished by the
kinase activities associated with early transcribed Clb3, Clb4, and
Clb5, which begin to accumulate soon after cells' passage through
start. This role of early Clbs is essential such that, in the absence
of Clb3, Clb4, and Clb5, cells fail to enter mitosis due to a lack of
Clb2 (and Clb1) proteins.
The inability of the clb5
mutant to build up Clb2 protein
to wild-type levels and to phosphorylate Hct1 efficiently provided the
initial clue (Fig. 1 and 3). The severity of this defect becomes starkly apparent in cells deficient in Clb3, Clb4, and Clb5. The clb3
clb4
clb5
cells fail to
accumulate Clb2 (and most likely Clb1) and therefore arrest in
G2/M without mitotic spindles (Fig. 2). The fact
that the deletion of the HCT1 gene restores viability and
Clb2 accumulation in these cells strongly suggests that the low level
of Clb2 in clb3
clb4
clb5
cells is due to their inability to inactivate Hct1 (Fig. 4). The
instability of ectopically expressed Clb2 and insufficient
phosphorylation of Hct1 in clb3
clb4
clb5
cells are both consistent with this hypothesis (Fig.
2D and 3). It should be noted that a sizable proportion of
clb3
clb4
clb5
hct1
cells divide several times but die before forming a
colony. This may be due to the buildup of a physiological imbalance
caused by growth in the presence of multiple deletions to which some cells are unable to develop tolerance. Nevertheless, these results underscore the acute importance of shutting down proteolytic machinery in early S phase to allow the initial accumulation of Clb2 necessary for the initiation of the positive feedback loop for CLB2
transcription (1). They also strongly argue that the early
Clb kinases collectively play a critical role of allowing accumulation
of late mitotic cyclin for the onset of mitosis. The involvement of
cyclin A in the accumulation of B-type cyclin (late cyclins) in
mammalian cells has been reported earlier (10).
Our findings have a number of important implications. First, it has
been suggested that Cdc20 facilitates mitotic exit by mediating Clb5
destruction in metaphase. This was based on the observation that a
mutation in CLB5 allows a cdc20
pds1
double mutant to exit mitosis (14). We
suspect that the reason why a mutation in CLB5 allows
cdc20
pds1
cells to exit mitosis is that,
in the absence of Clb5 function, the collective Clb kinase activities
do not rise to the wild-type level (Fig. 1); consequently, Hct1 is not
completely inactivated and cells no longer require Cdc20 function to
reduce the kinase activities any further in order to effectively
activate Hct1. We have also found that, in the absence of Pds1, cells'
ability to build up Clb2-Cdc28 kinase is also compromised (data not
shown). Second, our results also suggest that clb3
clb4
clb5
cells are inviable not because Clb5 is required for mitotic spindle formation in the absence of Clb3
and Clb4, as previously suggested (13); instead, a
collectively essential function of the early expressed Clb3, Clb4, and
Clb5 cyclins is to inactivate APCHct1 to make way
for the accumulation of late mitotic cyclins. Third, the early
Clb-Cdc28 kinases play a critical role in the inactivation of the
mitotic proteolytic machinery in early S phase (Fig. 5); however, the
possibility that Cln-Cdc28 kinases may contribute toward this
inactivation during the early part of the division cycle cannot be
completely ruled out. Last, the accumulation of Clb2 (and Clb1) is not
a simple consequence of turning on CLB2 transcription; the
inactivation of the cyclin destruction machinery plays a critical role
in bringing the transcriptional positive feedback loop into effect.
Complex processes such as mitosis are quite finely tuned to allow cells
to adapt to changing intra- and extracellular contexts. For a process
to be well honed, its on-off controls have to be overlaid with
mechanisms that regulate the thresholds of activities of various
effectors. Very often, the critical threshold of an effector is a
result of interactions between multiple events. Our investigations
suggest that the oscillatory pattern in cyclin abundance results from
the interwoven functional relationships between various players.
Central to these interactions is the antagonistic relationship between
the APC and the Clb proteins. In our previous work, we had established
that APCCdc20 and APCHct1
together inactivate the Clb kinases during mitosis (22).
Here we have shown that APCHct1 is inactivated in
early S phase of the subsequent cycle by early transcribed Clb3, Clb4,
and Clb5 kinases to allow accumulation of late mitotic cyclin Clb2. In
combination, these two sets of regulation can be seen to constitute a
two-stroke engine. The forward stroke occurs in S phase when Clb2
accumulates as a result of APCHct1 inhibition by
early Clb kinases. During the second (reverse) stroke,
APCHct1 (activated by
APCCdc20 and Cdc14) destroys Clb2 during mitosis.
The occurrence of these two steps in tandem would therefore generate
oscillations in Clb2 abundance. In a two-stroke process, it is
important that, at the end of one stroke, the reverse stroke is
initiated efficiently. In G2/M, the reverse
stroke is set in motion by the active APCCdc20,
which begins the process of APCHct1 activation.
This stroke leads to full activation of APCHct1
and complete destruction of Clb2. However, it is reversed again in
early S phase when early transcribed Clb3, Clb4, and Clb5 inactivate APCHct1, making way for Clb2 accumulation. These
functional relationships are schematically depicted in Fig.
7.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 7.
A schematic depicting the interaction between APC and
Clb proteins and the resulting oscillations in Clb2 abundance (see the
text for details).
|
|
This study has taken a renewed look at the familiar oscillatory pattern
in mitotic cyclins and has revealed the dynamic relationships that
generate it. It also suggests that events which occur early in the
division cycle (such as the inhibition of APCHct1
by Clb3, Clb4, and Clb5) have profound influence on the events in late
mitosis. We suspect that many apparently simple patterns of cellular
behavior emerge from such nonlinear functional interactions. These
intertwined relationships are what make cells resilient and adaptable systems.
 |
ACKNOWLEDGMENTS |
We are grateful to Wolfgang Zachariae, Bruce Futcher, and David
Morgan for various plasmids and constructs. We thank Shannon Allan for
the CDC14-GFP construct and Bor Luen Tang for 12CA5 ascites.
This work was supported by the National Science and Technology Board, Singapore.
F.M.Y. and H.H.L. contributed equally to the work.
U.S. is an adjunct staff member of the Department of Pharmacology,
National University of Singapore.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute of
Molecular and Cell Biology, 30 Medical Dr., Singapore 117609, Singapore. Phone: (65) 7743612, 8743518, or 8746680. Fax: (65) 7791117. E-mail: mcbucs{at}imcb.nus.edu.sg.
 |
REFERENCES |
| 1.
|
Amon, A.,
M. Tyers,
B. Futcher, and K. Nasmyth.
1993.
Mechanisms that help the yeast cell cycle clock tick: G2 cyclins transcriptionally activate G2 cyclins and repress G1 cyclins.
Cell
74:993-1007[CrossRef][Medline].
|
| 2.
|
Amon, A.,
S. Irniger, and K. Nasmyth.
1994.
Closing the cell cycle circle in yeast: G2 cyclin proteolysis initiated at mitosis persists until the activation of G1 cyclins in the next cycle.
Cell
77:1037-1050[CrossRef][Medline].
|
| 3.
|
Baumer, M.,
G. H. Braus, and S. Irniger.
2000.
Two different modes of cyclin Clb2 proteolysis during mitosis in Saccharomyces cerevisiae.
FEBS Lett.
468:142-148[CrossRef][Medline].
|
| 4.
|
Breeden, L.
2000.
Cyclin transcription: timing is everything.
Curr. Biol.
10:R586-R588[CrossRef][Medline].
|
| 5.
|
Fitch, I.,
C. Dahman,
U. Surana,
A. Amon,
L. Goetsch,
B. Byers, and B. Futcher.
1992.
Characterization of four B-type cyclin genes of the budding yeast S. cerevisiae.
Mol. Biol. Cell
3:805-818[Abstract].
|
| 6.
|
Jasperson, S. L.,
J. F. Charles, and D. O. Morgan.
1999.
Inhibitory phosphorylation of the APC regulator Hct1 is controlled by the kinase Cdc28 and the phosphatase Cdc14.
Curr. Biol.
9:227-236[CrossRef][Medline].
|
| 7.
|
Kramer, E. R.,
N. Scheuringer,
A. V. Podtelejnikov,
M. Mann, and J. M. Peters.
2000.
Mitotic regulation of the APC activator proteins CDC20 and CDH1.
Mol. Biol. Cell
11:1555-1569[Abstract/Free Full Text].
|
| 8.
|
Lim, H. H.,
P.-Y. Goh, and U. Surana.
1996.
Spindle pole body separation in Saccharomyces cerevisiae requires dephosphorylation of the tyrosine 19 residue of Cdc28.
Mol. Cell. Biol.
16:6385-6397[Abstract].
|
| 9.
|
Lim, H. H.,
P.-Y. Goh, and U. Surana.
1998.
Cdc20 is essential for APC-mediated proteolysis of both Pds1 and Clb2 during M phase in budding yeast.
Curr. Biol.
8:231-234[CrossRef][Medline].
|
| 10.
|
Lukas, C.,
C. S. Sorensen,
E. Kramer,
E. Santoni-Rugiu,
C. Lindeneg,
J. M. Peters,
J. Bartek, and J. Lukas.
1999.
Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex.
Nature
401:815-818[CrossRef][Medline].
|
| 11.
|
Nougarede, R.,
F. Della Seta,
P. Zarzov, and E. Schwob.
2000.
Hierarchy of S-phase-promoting factors: yeast Dbf4-Cdc7 kinase requires prior S-phase cyclin-dependent kinase activation.
Mol. Cell. Biol.
20:3795-3806[Abstract/Free Full Text].
|
| 12.
|
Schwab, M.,
A. S. Lutum, and W. Seufert.
1997.
Yeast Hct1 is a regulator of Clb2 cyclin proteolysis.
Cell
90:683-693[CrossRef][Medline].
|
| 13.
|
Schwob, E., and K. Nasmyth.
1993.
CLB5 and CLB6, a new pair of B cyclins involved in DNA replication in Saccharomyces cerevisiae.
Genes Dev.
7:1160-1175[Abstract/Free Full Text].
|
| 14.
|
Shirayama, M.,
A. Toth,
M. Galova, and K. Nasmyth.
1999.
APCCdc20 promotes exit from mitosis by destroying the anaphase inhibitor Pds1 and cyclin Clb5.
Nature
402:203-207[CrossRef][Medline].
|
| 15.
|
Shou, W.,
J. H. Seol,
A. Shevchenko,
C. Baskerville,
D. Moazed,
Z. W. Chen,
J. Jang,
A. Shevchenko,
H. Charbonneau, and R. J. Deshaies.
1999.
Exit from mitosis is triggered by Tem1-dependent release of the protein phosphatase Cdc14 from nucleolar RENT complex.
Cell
97:233-244[CrossRef][Medline].
|
| 16.
|
Surana, U.,
H. Robitsch,
C. Price,
T. Schuster,
I. Fitch,
A. B. Futcher, and K. Nasmyth.
1991.
The role of CDC28 and cyclins during mitosis in the budding yeast S. cerevisiae.
Cell
65:145-161[CrossRef][Medline].
|
| 17.
|
Surana, U.,
A. Amon,
C. Dowzer,
J. Mcgrew,
B. Byers, and K. Nasmyth.
1993.
Destruction of the CDC28/CLB mitotic kinase is not required for metaphase to anaphase transition in budding yeast.
EMBO J.
12:1969-1978[Medline].
|
| 18.
|
Visintin, R.,
S. Prinz, and A. Amon.
1997.
CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis.
Science
278:460-463[Abstract/Free Full Text].
|
| 19.
|
Visintin, R.,
K. Craig,
E. S. Hwang,
S. Prinz,
M. Tyres, and A. Amon.
1998.
The phosphatase Cdc14 triggers mitotic exit by reversal of Cdk-dependent phosphorylation.
Mol. Cell
2:709-718[CrossRef][Medline].
|
| 20.
|
Visintin, R.,
E. S. Hwang, and A. Amon.
1999.
Cfi1 prevents premature exit from mitosis by anchoring Cdc14 phosphatase in the nucleolus.
Nature
398:818-823[CrossRef][Medline].
|
| 21.
|
Yamamoto, A.,
V. Guacci, and D. Koshland.
1996.
Pds1p is required for faithful execution of anaphase in the yeast Saccharomyces cerevisiae.
J. Cell Biol.
133:85-97[Abstract/Free Full Text].
|
| 22.
|
Yeong, F. M.,
H. H. Lim,
C. G. Padmashree, and U. Surana.
2000.
Exit from mitosis in budding yeast: biphasic inactivation of the Cdc28-Clb2 mitotic kinase and the role of Cdc20.
Mol. Cell
5:501-511[CrossRef][Medline].
|
| 23.
|
Zachariae, W.,
M. Schwab,
K. Nasmyth, and W. Seufert.
1998.
Control of cyclin ubiquitination by CDK-regulated binding of Hct1 to the anaphase promoting complex.
Science
282:1721-1724[Abstract/Free Full Text].
|
| 24.
|
Zachariae, W.,
A. Shevchenko,
P. D. Andrews,
M. J. R. Stark,
M. Mann, and K. Nasmyth.
1998.
Mass spectrometric analysis of the anaphase complex from budding yeast: identification of a subunit related to cullins.
Science
279:1216-1219[Abstract/Free Full Text].
|
| 25.
|
Zachariae, W.
1999.
Progression into and out of mitosis.
Curr. Opin. Cell Biol.
11:708-716[CrossRef][Medline].
|
| 26.
|
Zachariae, W., and K. Nasmyth.
1999.
Whose end is destruction: cell division and the anaphase-promoting complex.
Genes Dev.
13:2039-2058[Free Full Text].
|
Molecular and Cellular Biology, August 2001, p. 5071-5081, Vol. 21, No. 15
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.15.5071-5081.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sari, F., Braus, G. H., Irniger, S.
(2007). A Process Independent of the Anaphase-promoting Complex Contributes to Instability of the Yeast S Phase Cyclin Clb5. J. Biol. Chem.
282: 26614-26622
[Abstract]
[Full Text]
-
Di Fiore, B., Pines, J.
(2007). Emi1 is needed to couple DNA replication with mitosis but does not regulate activation of the mitotic APC/C. JCB
177: 425-437
[Abstract]
[Full Text]
-
Ikui, A. E., Archambault, V., Drapkin, B. J., Campbell, V., Cross, F. R.
(2007). Cyclin and Cyclin-Dependent Kinase Substrate Requirements for Preventing Rereplication Reveal the Need for Concomitant Activation and Inhibition. Genetics
175: 1011-1022
[Abstract]
[Full Text]
-
Dial, J. M., Petrotchenko, E. V., Borchers, C. H.
(2007). Inhibition of APCCdh1 Activity by Cdh1/Acm1/Bmh1 Ternary Complex Formation. J. Biol. Chem.
282: 5237-5248
[Abstract]
[Full Text]
-
Pic-Taylor, A., Darieva, Z., Morgan, B. A., Sharrocks, A. D.
(2004). Regulation of Cell Cycle-Specific Gene Expression through Cyclin-Dependent Kinase-Mediated Phosphorylation of the Forkhead Transcription Factor Fkh2p. Mol. Cell. Biol.
24: 10036-10046
[Abstract]
[Full Text]
-
Tarayre, S., Vinardell, J. M., Cebolla, A., Kondorosi, A., Kondorosi, E.
(2004). Two Classes of the Cdh1-Type Activators of the Anaphase-Promoting Complex in Plants: Novel Functional Domains and Distinct Regulation. Plant Cell
16: 422-434
[Abstract]
[Full Text]
-
Ross, K. E., Cohen-Fix, O.
(2003). The Role of Cdh1p in Maintaining Genomic Stability in Budding Yeast. Genetics
165: 489-503
[Abstract]
[Full Text]
-
Cowart, L. A., Okamoto, Y., Pinto, F. R., Gandy, J. L., Almeida, J. S., Hannun, Y. A.
(2003). Roles for Sphingolipid Biosynthesis in Mediation of Specific Programs of the Heat Stress Response Determined through Gene Expression Profiling. J. Biol. Chem.
278: 30328-30338
[Abstract]
[Full Text]
-
Harper, J. W., Burton, J. L., Solomon, M. J.
(2002). The anaphase-promoting complex: it's not just for mitosis any more. Genes Dev.
16: 2179-2206
[Full Text]
-
Bolte, M., Steigemann, P., Braus, G. H., Irniger, S.
(2002). Inhibition of APC-mediated proteolysis by the meiosis-specific protein kinase Ime2. Proc. Natl. Acad. Sci. USA
99: 4385-4390
[Abstract]
[Full Text]
-
Bolte, M., Steigemann, P., Braus, G. H., Irniger, S.
(2002). Inhibition of APC-mediated proteolysis by the meiosis-specific protein kinase Ime2. Proc. Natl. Acad. Sci. USA
99: 4385-4390
[Abstract]
[Full Text]